This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Alphabeta Ab, Biophos Ag. Active years: 2011-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Älvsjö{umlaut over ( )}, SE (2011)
- Stockholm, SE (2018)
Company Filing History:
Years Active: 2011-2018
Title: Lennart Nilsson: Innovator in Alzheimer's Disease Research
Introduction
Lennart Nilsson is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of molecular biochemistry and medicine, particularly in the context of Alzheimer's disease.
Latest Patents
Lennart Nilsson holds a patent titled "Ligands for prevention of neurotoxicity of the Alzheimer's disease related amyloid-beta peptide." This invention focuses on ligands that comprise modified amino acid residues, targeting the amyloid-β peptide associated with Alzheimer's disease. The aim is to prevent aggregation and neurotoxicity, with potential applications as drugs for the treatment of Alzheimer's disease.
Career Highlights
Nilsson's work has been instrumental in advancing our understanding of Alzheimer's disease and developing therapeutic strategies. His innovative approach to targeting amyloid-beta peptides has opened new avenues for research and treatment.
Collaborations
Lennart has collaborated with notable colleagues, including Roger Strömberg and Dmytro Honcharenko, contributing to a dynamic research environment.
Conclusion
Lennart Nilsson's contributions to Alzheimer's disease research through his patent and collaborative efforts highlight his role as an important figure in the field of molecular biochemistry. His work continues to inspire advancements in the treatment of neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile